Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania (vol 20, 738, 2020)

被引：0
|
作者：
Hunter, Olivia F. [1 ]
Kyesi, Furaha [2 ]
Ahluwalia, Amrit Kaur [1 ]
Daffe, Zeinabou Niame [1 ]
Munseri, Patricia [3 ]
von Reyn, C. Fordham [4 ]
Adams, Lisa V. [5 ]
机构：
[1] Dartmouth Coll, Hanover, NH 03755 USA
[2] Minist Hlth Community Dev Gender Elderly & Chi, Dodoma, Tanzania
[3] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania
[4] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA
[5] Geisel Sch Med Dartmouth, Hanover, NH 03755 USA
来源：
BMC INFECTIOUS DISEASES | 2020年 / 20卷 / 01期
关键词：
D O I：
10.1186/s12879-020-05514-5
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
An amendment to this paper has been published and can be accessed via the original article.
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Modeling the implementation of population-level isoniazid preventive therapy for tuberculosis control in a high HIV-prevalence setting
    Rhines, Allison S.
    Feldman, Marcus W.
    Bendavid, Eran
    [J]. AIDS, 2018, 32 (15) : 2129 - 2140
  • [32] Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study
    Russom, Mulugeta
    Jeannetot, Daniel Y. B.
    Tesfamariam, Sirak
    Stricker, Bruno H.
    Verhamme, Katia
    [J]. RISK MANAGEMENT AND HEALTHCARE POLICY, 2022, 15 : 1407 - 1419
  • [33] Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania
    Grace A. Shayo
    Candida Moshiro
    Said Aboud
    Muhammad Bakari
    Ferdinand M. Mugusi
    [J]. BMC Infectious Diseases, 15
  • [34] Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study
    Amon Sabasaba
    Henry Mwambi
    Geoffrey Somi
    Angella Ramadhani
    Michael J. Mahande
    [J]. BMC Infectious Diseases, 19
  • [35] Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study
    Sabasaba, Amon
    Mwambi, Henry
    Somi, Geoffrey
    Ramadhani, Angella
    Mahande, Michael J.
    [J]. BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [36] Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania
    Shayo, Grace A.
    Moshiro, Candida
    Aboud, Said
    Bakari, Muhammad
    Mugusi, Ferdinand M.
    [J]. BMC INFECTIOUS DISEASES, 2015, 15
  • [37] Assessment of contextual factors shaping delivery and uptake of isoniazid preventive therapy among people living with HIV in Dar es salaam, Tanzania
    Renatus Fabiano Nyarubamba
    Adam Silumbwe
    Choolwe Jacobs
    Patricia Maritim
    Paschal Mdoe
    Joseph Mumba Zulu
    [J]. BMC Infectious Diseases, 22
  • [38] Factors associated with uptake of isoniazid preventive therapy among children living with HIV in Mwanza region, Tanzania: a cross-sectional study
    Tuwa, Ally
    Okia, David
    Nantale, Ritah
    Jaka, Hyasinta
    Alunyo, Jimmy Patrick
    Mukunya, David
    Matovu, Joseph K. B.
    Kibuule, Dan
    [J]. BMC PUBLIC HEALTH, 2024, 24 (01)
  • [39] Assessment of contextual factors shaping delivery and uptake of isoniazid preventive therapy among people living with HIV in Dar es salaam, Tanzania
    Nyarubamba, Renatus Fabiano
    Silumbwe, Adam
    Jacobs, Choolwe
    Maritim, Patricia
    Mdoe, Paschal
    Zulu, Joseph Mumba
    [J]. BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [40] Point-of-Care C-Reactive Protein Testing to Facilitate Implementation of Isoniazid Preventive Therapy for People Living With HIV
    Yoon, Christina
    Davis, J. Lucian
    Huang, Laurence
    Muzoora, Conrad
    Byakwaga, Helen
    Scibetta, Colin
    Bangsberg, David R.
    Nahid, Payam
    Semitala, Fred C.
    Hunt, Peter W.
    Martin, Jeffrey N.
    Cattamanchi, Adithya
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (05) : 551 - 556
12345